stockrowAbsci Corporation (ABSI) vs Intellia Therapeutics, Inc. (NTLA)
- Absci Corporation ABSI 10.16 +8.20%
- Intellia Therapeutics, Inc. NTLA 11.27 +1.53%
Absci Corporation and Intellia Therapeutics, Inc. are both Biotechnology companies. Absci Corporation and Intellia Therapeutics, Inc. are of similar size ($1.6B and $1.6B). Intellia Therapeutics, Inc. grew revenue faster over the last twelve months: −8.07% against −62.3%. Intellia Therapeutics, Inc. has the higher net margin (−805.8% vs −7,756.4%) and the lower return on invested capital (−195.3% vs −174.7%). Across the 17 metrics below, Intellia Therapeutics, Inc. leads on 12 and Absci Corporation on 5.
Valuation
Profitability
| Metric | ABSI | NTLA | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 68.51% |
| Operating margin | (8,084.50%) | (821.24%) | 0.00% |
| Net margin | (7,756.37%) | (805.75%) | 0.00% |
| Free cash flow margin | (6,969.83%) | (671.57%) | 0.00% |
| Return on equity | (57.72%) | (62.60%) | (51.96%) |
| Return on assets | (50.57%) | (46.63%) | (46.06%) |
| Return on invested capital | (174.74%) | (195.32%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack